N-Glycoprofiling Analysis for Carbohydrate Composition and Site-Occupancy Determination in a Poly-Glycosylated Protein: Human Thyrotropin of Different Origins
Authors:
- Maria Teresa C. P. RibelaMRMaria Teresa C. P. Ribela
- Renata DamianiRDRenata Damiani
- Felipe D. SilvaFSFelipe D. Silva
- Eliana R. LimaELEliana R. Lima
- João E. OliveiraJOJoão E. Oliveira
- Cibele N. PeroniCPCibele N. Peroni
- Peter A. TorjesenPTPeter A. Torjesen
- Carlos R. SoaresCSCarlos R. Soares
- Paolo BartoliniPBPaolo Bartolini
Open Access
- 3 February 2017
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (2) , 131
Abstract
Human thyrotropin (hTSH) is a glycoprotein with three potential glycosylation sites: two in the α-subunit and one in the β-subunit. These sites are not always occupied and occupancy is frequently neglected in glycoprotein characterization, even though it is related to folding, trafficking, initiation of inflammation and host defense, as well as congenital disorders of glycosylation (CDG). For the first time N-glycoprofiling analysis was applied to the site-occupancy determination of two native pituitary hTSH, in comparison with three recombinant preparations of hTSH, a widely used biopharmaceutical. A single methodology provided the: (i) average N-glycan mass; (ii) mass fraction of each monosaccharide and of sulfate; and (iii) percent carbohydrate. The results indicate that the occupancy (65%–87%) and carbohydrate mass (12%–19%) can be up to 34%–57% higher in recombinant hormones. The average glycan mass is 24% lower in pituitary hTSH and contains ~3-fold fewer moles of galactose (p < 0.005) and sialic acid (p < 0.01). One of the two native preparations, which had the smallest glycan mass together with the lowest occupancy and GalNAc, sulfate, Gal and sialic acid contents, also presented the lowest in vivo bioactivity and circulatory half-life. The methodology described, comparing a recombinant biopharmaceutical to its native equivalent, can be applied to any physiologically or clinical relevant glycoprotein.Keywords
This publication has 47 references indexed in Scilit:
- CSF N-Glycan Profiles to Investigate Biomarkers in Brain Developmental Disorders: Application to Leukodystrophies Related to eIF2B MutationsPLOS ONE, 2012
- A comparative study of glycoprotein concentration, glycoform profile and glycosylation site occupancy using isotope labeling and electrospray linear ion trap mass spectrometryAnalytica Chimica Acta, 2012
- Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer managementCurrent Opinion in Oncology, 2010
- Mass spectrometry in the characterization of human genetic N‐glycosylation defectsMass Spectrometry Reviews, 2008
- All-or-none N-glycosylation in primate follicle-stimulating hormone β-subunitsMolecular and Cellular Endocrinology, 2007
- Present status of the use of recombinant human TSH in thyroid cancer managementActa Oncologica, 2006
- Hormone-Specific Inhibitory Influence of α-Subunit Asn56 Oligosaccharide on In Vitro Subunit Association and Follicle-Stimulating Hormone Receptor Binding of Equine Gonadotropins1Biology of Reproduction, 1998
- Tryptic mapping of human chorionic gonadotropin by matrix‐assisted laser desorption/ionization mass spectrometryRapid Communications in Mass Spectrometry, 1995
- Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltonsAnalytical Chemistry, 1988
- Pituitary glycoprotein hormone oligosaccharides: Structure, synthesis and function of the asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropinBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1988